Ikematsu Y - Search Results

1

Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non-small cell lung cancer.

Furukawa R, Inoue H, Yoneshima Y, Tsutsumi H, Iwama E, Ikematsu Y, Ando N, Shiraishi Y, Ota K, Tanaka K, Nakanishi Y, Okamoto I. Furukawa R, et al. Among authors: ikematsu y. Lung Cancer. 2021 May;155:144-150. doi: 10.1016/j.lungcan.2021.03.018. Epub 2021 Mar 26. Lung Cancer. 2021. PMID: 33819860 Free article.

2

Marked response to pembrolizumab in a patient with pulmonary pleomorphic carcinoma highly positive for PD-L1.

Ikematsu Y, Yoneshima Y, Ijichi K, Tanaka K, Harada T, Oda Y, Nakanishi Y, Okamoto I. Ikematsu Y, et al. Lung Cancer. 2017 Oct;112:230-231. doi: 10.1016/j.lungcan.2017.07.020. Epub 2017 Jul 21. Lung Cancer. 2017. PMID: 28754417 No abstract available.

3

Expression of PD-1 and PD-L1 on cytotoxic T lymphocytes and immune deficiency in a patient with adult T cell leukemia/lymphoma.

Yanagihara T, Ikematsu Y, Kato K, Yonekawa A, Ideishi S, Tochigi T, Sugio T, Miyawaki K, Tanaka K, Harada E, Hamada N, Nakanishi Y. Yanagihara T, et al. Among authors: ikematsu y. Ann Hematol. 2018 Feb;97(2):359-360. doi: 10.1007/s00277-017-3146-z. Epub 2017 Oct 2. Ann Hematol. 2018. PMID: 28967040 No abstract available.

4

Detection of identical T cell clones in peritumoral pleural effusion and pneumonitis lesions in a cancer patient during immune-checkpoint blockade.

Tanaka K, Yanagihara T, Ikematsu Y, Inoue H, Ota K, Kashiwagi E, Suzuki K, Hamada N, Takeuchi A, Tatsugami K, Eto M, Ijichi K, Oda Y, Otsubo K, Yoneshima Y, Iwama E, Nakanishi Y, Okamoto I. Tanaka K, et al. Among authors: ikematsu y. Oncotarget. 2018 Jul 17;9(55):30587-30593. doi: 10.18632/oncotarget.25743. eCollection 2018 Jul 17. Oncotarget. 2018. PMID: 30093971 Free PMC article.

5

Immune checkpoint protein and cytokine expression by T lymphocytes in pleural effusion of cancer patients receiving anti-PD-1 therapy.

Ikematsu Y, Tanaka K, Yanagihara T, Liu R, Inoue H, Yoneshima Y, Ota K, Iwama E, Takata S, Hata K, Takahata Y, Wataya H, Nakanishi Y, Okamoto I. Ikematsu Y, et al. Lung Cancer. 2019 Dec;138:58-64. doi: 10.1016/j.lungcan.2019.10.011. Epub 2019 Oct 13. Lung Cancer. 2019. PMID: 31639551 Free article.

6

Immune-checkpoint profiles for T cells in bronchoalveolar lavage fluid of patients with immune-checkpoint inhibitor-related interstitial lung disease.

Suzuki K, Yanagihara T, Matsumoto K, Kusaba H, Yamauchi T, Ikematsu Y, Tanaka K, Otsubo K, Inoue H, Yoneshima Y, Iwama E, Arimura-Omori M, Harada E, Hamada N, Okamoto I, Nakanishi Y. Suzuki K, et al. Among authors: ikematsu y. Int Immunol. 2020 Jul 28;32(8):547-557. doi: 10.1093/intimm/dxaa022. Int Immunol. 2020. PMID: 32253426

7

NEUROD1 is highly expressed in extensive-disease small cell lung cancer and promotes tumor cell migration.

Ikematsu Y, Tanaka K, Toyokawa G, Ijichi K, Ando N, Yoneshima Y, Iwama E, Inoue H, Tagawa T, Nakanishi Y, Okamoto I. Ikematsu Y, et al. Lung Cancer. 2020 Aug;146:97-104. doi: 10.1016/j.lungcan.2020.05.012. Epub 2020 May 24. Lung Cancer. 2020. PMID: 32526603

8

Association of Mps one binder kinase activator 1 (MOB1) expression with poor disease-free survival in individuals with non-small cell lung cancer.

Ando N, Tanaka K, Otsubo K, Toyokawa G, Ikematsu Y, Ide M, Yoneshima Y, Iwama E, Inoue H, Ijichi K, Tagawa T, Nakanishi Y, Okamoto I. Ando N, et al. Among authors: ikematsu y. Thorac Cancer. 2020 Oct;11(10):2830-2839. doi: 10.1111/1759-7714.13608. Epub 2020 Aug 25. Thorac Cancer. 2020. PMID: 32841529 Free PMC article.

9

Integrated Immunohistochemical Study on Small-Cell Carcinoma of the Lung Focusing on Transcription and Co-Transcription Factors.

Sato Y, Okamoto I, Kameyama H, Kudoh S, Saito H, Sanada M, Kudo N, Wakimoto J, Fujino K, Ikematsu Y, Tanaka K, Nishikawa A, Sakaguchi R, Ito T. Sato Y, et al. Among authors: ikematsu y. Diagnostics (Basel). 2020 Nov 13;10(11):949. doi: 10.3390/diagnostics10110949. Diagnostics (Basel). 2020. PMID: 33202998 Free PMC article.

10

Standard therapy-resistant small cell lung cancer showing dynamic transition of neuroendocrine fate during the cancer trajectory: A case report.

Ito F, Sato T, Emoto K, Kaizuka N, Yagi K, Watanabe R, Hashiguchi MH, Ninomiya H, Ikematsu Y, Tanaka K, Domoto H, Shiomi T. Ito F, et al. Among authors: ikematsu y. Mol Clin Oncol. 2021 Dec;15(6):261. doi: 10.3892/mco.2021.2423. Epub 2021 Oct 20. Mol Clin Oncol. 2021. PMID: 34790350 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page